ProgynyPGNY
PGNY
About: Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Employees: 680
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
206% more call options, than puts
Call options by funds: $11.7M | Put options by funds: $3.84M
75% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 36
17% more capital invested
Capital invested by funds: $1.44B [Q4 2024] → $1.68B (+$245M) [Q1 2025]
9% more funds holding
Funds holding: 264 [Q4 2024] → 287 (+23) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]
5% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 95
9.63% less ownership
Funds ownership: 97.69% [Q4 2024] → 88.07% (-9.63%) [Q1 2025]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$21
10%
downside
Avg. target
$25
6%
upside
High target
$28
21%
upside
2 analyst ratings
1 positive
50%
1 neutral
50%
0 negative
0%
Leerink Partners Michael Cherny | 21%upside $28 | Outperform Upgraded | 8 Jul 2025 |
Canaccord Genuity Richard Close | 10%downside $21 | Hold Maintained | 12 May 2025 |
Financial journalist opinion
Based on 4 articles about PGNY published over the past 30 days
Neutral
GlobeNewsWire
1 day ago
Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced a new partnership with ŌURA , maker of the world's leading smart ring, further empowering women to better understand and take action on their health through comprehensive data and personalized insights.
Positive
Zacks Investment Research
2 days ago
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength?
Progyny (PGNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Neutral
GlobeNewsWire
3 days ago
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report
Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance
Neutral
GlobeNewsWire
2 weeks ago
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health
With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering
Neutral
GlobeNewsWire
1 month ago
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits. The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.
Neutral
GlobeNewsWire
1 month ago
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors.
Neutral
GlobeNewsWire
1 month ago
Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the appointment of Morehouse School of Medicine's Regional Dean for Seattle and Puget Sound's Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow of the American College of Obstetricians & Gynecologists (FACOG), and a Menopause Society Certified Practitioner (MSCP) – and Columbia University's Dr. Whitney Booker – a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine – to its Medical Advisory Board. “As Progyny continues to be at the forefront of women's health, we are proud to welcome two deeply respected clinical leaders whose unique training and lived experience will bring critical insights to our work,” said Dr. Janet Choi, Chief Medical Officer at Progyny.
Neutral
GlobeNewsWire
1 month ago
Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Progyny's Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time.
Neutral
Seeking Alpha
2 months ago
Progyny, Inc. (PGNY) Q1 2025 Earnings Call Transcript
Progyny, Inc. (NASDAQ:PGNY ) Q1 2025 Results Conference Call May 8, 2025 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Pete Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Securities David Larsen - BTIG Sarah James - Cantor Fitzgerald Operator Good day, ladies and gentlemen, and welcome to the Progyny Inc. First Quarter 2025 Earnings Conference Call. At this time all participants are in a listen-only mode and the floor will be opened for questions and comments after the presentation.
Positive
Zacks Investment Research
2 months ago
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates
Progyny (PGNY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.39 per share a year ago.
Charts implemented using Lightweight Charts™